InsidersTradesSigma
Track the Sopharma AD share price and the full management transaction log of the company, a publicly traded company based in Bulgaria. Shares are quoted on the BG market, under the authority of BSE-Sofia (FSC). Operating in the Health Care sector, Sopharma AD has recorded 50 insider filings. Market capitalisation: €3.8bn. The latest transaction was disclosed on 26 May 2026 (MAR Art. 17 — Insider information). Among the most active insiders: Pelagia Viatcheva. The full history is openly available.
50
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€32,525
1 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,533 of 28,752 companies
39.9
score / 100
Value28
Quality52
FCF yld-1.6%
Earn yld1.6%
EV/EBITDA32.8x
ROE17%
Gross mgn23%
Net mgn4.9%
Debt/EBITDA2.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 May 2026
Declarations50 total
17,485 shares@ €1.8602100.0% of flowShareXBULBSE-BG:155942
25 of 50 declarations
About Sopharma AD
Sopharma AD is a Bulgarian company engaged in the production and distribution of pharmaceuticals. It is listed on the Bulgarian Stock Exchange under the symbol XBUL.